The impact of lockdown enforcement during the SARSCoV-2 pandemic on the timing of presentation and early outcomes of patients with ST-elevation myocardial infarction.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 07 08 2020
accepted: 08 10 2020
entrez: 23 10 2020
pubmed: 24 10 2020
medline: 22 12 2020
Statut: epublish

Résumé

Early reports described decreased admissions for acute cardiovascular events during the SarsCoV-2 pandemic. We aimed to explore whether the lockdown enforced during the SARSCoV-2 pandemic in Israel impacted the characteristics of presentation, reperfusion times, and early outcomes of ST-elevation myocardial infarction (STEMI) patients. A multicenter prospective cohort comprising all STEMI patients treated by primary percutaneous coronary intervention admitted to four high-volume cardiac centers in Israel during lockdown (20/3/2020-30/4/2020). STEMI patients treated during the same period in 2019 served as controls. The study comprised 243 patients, 107 during the lockdown period of 2020 and 136 during the same period in 2019, with no difference in demographics and clinical characteristics. Patients admitted in 2020 had higher admission and peak troponin levels, had a 2.4 fold greater likelihood of Door-to-balloon times> 90 min (95%CI: 1.2-4.9, p = 0.01) and 3.3 fold greater likelihood of pain-to-balloon times> 12 hours (OR 3.3, 95%CI: 1.3-8.1, p<0.01). They experienced higher rates hemodynamic instability (25.2% vs 14.7%, p = 0.04), longer hospital stay (median, IQR [4, 3-6 Vs 5, 4-6, p = 0.03]), and fewer early (<72 hours) discharge (12.4% Vs 32.4%, p<0.001). The lockdown imposed during the SARSCoV-2 pandemic was associated with a significant lag in the time to reperfusion of STEMI patients. Measures to improves this metric should be implemented during future lockdowns.

Identifiants

pubmed: 33095801
doi: 10.1371/journal.pone.0241149
pii: PONE-D-20-24693
pmc: PMC7584161
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0241149

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Eur Heart J. 2020 May 14;41(19):1852-1853
pubmed: 32297932
Circulation. 2004 Mar 16;109(10):1223-5
pubmed: 15007008
Eur Heart J Acute Cardiovasc Care. 2020 May 18;:2048872619886312
pubmed: 32419471
J Urban Health. 2005 Sep;82(3):358-63
pubmed: 16000653
J Am Coll Cardiol. 2020 Jun 9;75(22):2871-2872
pubmed: 32283124
N Engl J Med. 1996 Feb 15;334(7):413-9
pubmed: 8552142
Eur Heart J. 2020 Jun 7;41(22):2083-2088
pubmed: 32412631
Lancet. 1991 Sep 14;338(8768):660-1
pubmed: 1679475
Circ Cardiovasc Qual Outcomes. 2020 Apr;13(4):e006631
pubmed: 32182131
N Engl J Med. 2020 Jul 2;383(1):88-89
pubmed: 32343497
Eur Heart J. 2018 Jan 7;39(2):119-177
pubmed: 28886621
Can J Cardiol. 2020 Jul;36(7):1152-1155
pubmed: 32447060
J Am Heart Assoc. 2014 Dec 08;3(6):e001354
pubmed: 25488295

Auteurs

Ofer Kobo (O)

Department of Cardiology, Hillel Yaffe Medical Center, Hadera, Israel.

Roi Efraim (R)

Department of Cardiology, Rambam Health Care Campus, Haifa, Israel.

Majdi Saada (M)

Department of Cardiology, Hillel Yaffe Medical Center, Hadera, Israel.

Natalia Kofman (N)

Department of Cardiology, Shamir Medical Center, Zerifin, Israel.
Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Ala Abu Dogosh (A)

Department of Cardiology, Soroka University Medical Center, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer-Sheva, Israel.

Yigal Abramowitz (Y)

Department of Cardiology, Soroka University Medical Center, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer-Sheva, Israel.

Doron Aronson (D)

Department of Cardiology, Rambam Health Care Campus, Haifa, Israel.
Rappaport - Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.

Sa'ar Minha (S)

Department of Cardiology, Shamir Medical Center, Zerifin, Israel.
Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Ariel Roguin (A)

Department of Cardiology, Hillel Yaffe Medical Center, Hadera, Israel.
Rappaport - Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.

Simcha R Meisel (SR)

Department of Cardiology, Hillel Yaffe Medical Center, Hadera, Israel.
Rappaport - Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH